|
Name |
Thielavin J
|
| Molecular Formula | C29H30O10 | |
| IUPAC Name* |
4-[4-(2,4-dihydroxy-3,6-dimethylbenzoyl)oxy-2-methoxy-3,5,6-trimethylbenzoyl]oxy-2-hydroxy-3,6-dimethylbenzoic acid
|
|
| SMILES |
CC1=CC(=C(C(=C1C(=O)OC2=C(C(=C(C(=C2C)C)C(=O)OC3=C(C(=C(C(=C3)C)C(=O)O)O)C)OC)C)O)C)O
|
|
| InChI |
InChI=1S/C29H30O10/c1-11-9-18(30)15(5)23(31)21(11)28(35)39-25-14(4)13(3)22(26(37-8)17(25)7)29(36)38-19-10-12(2)20(27(33)34)24(32)16(19)6/h9-10,30-32H,1-8H3,(H,33,34)
|
|
| InChIKey |
RLLCMRPOSFZYJJ-UHFFFAOYSA-N
|
|
| Synonyms |
Thielavin J; 4-[4-(2,4-dihydroxy-3,6-dimethylbenzoyl)oxy-2-methoxy-3,5,6-trimethylbenzoyl]oxy-2-hydroxy-3,6-dimethylbenzoic acid
|
|
| CAS | NA | |
| PubChem CID | 10875192 | |
| ChEMBL ID | NA |
Chemical Classification: |
|
|
|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
|---|---|---|---|---|---|---|---|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
| Molecular Weight: | 538.5 | ALogp: | 6.8 |
| HBD: | 4 | HBA: | 10 |
| Rotatable Bonds: | 8 | Lipinski's rule of five: | Rejected |
| Polar Surface Area: | 160.0 | Aromatic Rings: | 3 |
| Heavy Atoms: | 39 | QED Weighted: | 0.236 |
| Caco-2 Permeability: | -5.711 | MDCK Permeability: | 0.00001230 |
| Pgp-inhibitor: | 0.367 | Pgp-substrate: | 0.875 |
| Human Intestinal Absorption (HIA): | 0.807 | 20% Bioavailability (F20%): | 0.122 |
| 30% Bioavailability (F30%): | 0.023 |
| Blood-Brain-Barrier Penetration (BBB): | 0.001 | Plasma Protein Binding (PPB): | 99.56% |
| Volume Distribution (VD): | 0.32 | Fu: | 1.00% |
| CYP1A2-inhibitor: | 0.048 | CYP1A2-substrate: | 0.931 |
| CYP2C19-inhibitor: | 0.054 | CYP2C19-substrate: | 0.063 |
| CYP2C9-inhibitor: | 0.621 | CYP2C9-substrate: | 0.1 |
| CYP2D6-inhibitor: | 0.002 | CYP2D6-substrate: | 0.119 |
| CYP3A4-inhibitor: | 0.054 | CYP3A4-substrate: | 0.09 |
| Clearance (CL): | 2.891 | Half-life (T1/2): | 0.474 |
| hERG Blockers: | 0.001 | Human Hepatotoxicity (H-HT): | 0.029 |
| Drug-inuced Liver Injury (DILI): | 0.873 | AMES Toxicity: | 0.025 |
| Rat Oral Acute Toxicity: | 0.601 | Maximum Recommended Daily Dose: | 0.672 |
| Skin Sensitization: | 0.452 | Carcinogencity: | 0.028 |
| Eye Corrosion: | 0.003 | Eye Irritation: | 0.918 |
| Respiratory Toxicity: | 0.261 |
| Similar NPs | Similar Drugs | ||||||
|---|---|---|---|---|---|---|---|
| NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
| ENC002085 | ![]() |
0.807 | D0WY9N | ![]() |
0.301 | ||
| ENC000992 | ![]() |
0.720 | D03RTK | ![]() |
0.252 | ||
| ENC003651 | ![]() |
0.702 | D0I3XG | ![]() |
0.246 | ||
| ENC005301 | ![]() |
0.697 | D04WJO | ![]() |
0.240 | ||
| ENC004140 | ![]() |
0.640 | D0L5FY | ![]() |
0.231 | ||
| ENC003680 | ![]() |
0.630 | D0FX2Q | ![]() |
0.230 | ||
| ENC003695 | ![]() |
0.587 | D06GCK | ![]() |
0.230 | ||
| ENC003758 | ![]() |
0.532 | D05QDC | ![]() |
0.230 | ||
| ENC004141 | ![]() |
0.509 | D0Q0PR | ![]() |
0.228 | ||
| ENC003732 | ![]() |
0.416 | D0N1FS | ![]() |
0.224 | ||